BioTech News at Arizona Biotech

Biotech News <<< Mailing List

Biotechnology News <<< Discussion Forums

Saturday, September 03, 2005
 
Bay Area biotech firms release terms of IPOs ITCA SNSS
Inside Bay Area - Business News

Bay Area biotech firms release terms of IPOs

Two Bay Area biotechnology firms announced terms for initial public offerings of stock.

Emeryville-based Intarcia Therapeutics Inc., which is developing breast cancer and hepatitis C treatments, Friday announced the terms for an IPO worth as much as $70 million.

The stock is expected to list on the Nasdaq Stock Market under the symbol "ITCA."

Underwriters for Sunesis Pharmaceuticals Inc. on Thursday set the terms of the company's pending IPO at 6 million shares with an estimated price range of between $9 and $11 a share.


Sunesis company said it plans to list its common stock on the Nasdaq National Market under the symbol "SNSS."

Arizona Biotech
Biotech News
Arizona Entrepreneurs
Arizona High Tech

Arizona Biotech

Biotech News

Arizona Entrepreneurs

Arizona High Tech

Comments: Post a Comment

<< Home

Powered by Blogger